Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $613000.0.

  • Rapid Micro Biosystems' Net Cash Flow rose 10406.58% to $613000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 7784.16%. This contributed to the annual value of -$7.3 million for FY2024, which is 16243.25% down from last year.
  • Latest data reveals that Rapid Micro Biosystems reported Net Cash Flow of $613000.0 as of Q3 2025, which was up 10406.58% from -$654000.0 recorded in Q2 2025.
  • Rapid Micro Biosystems' 5-year Net Cash Flow high stood at $119.5 million for Q3 2021, and its period low was -$115.9 million during Q1 2022.
  • Over the past 5 years, Rapid Micro Biosystems' median Net Cash Flow value was -$1.9 million (recorded in 2024), while the average stood at -$576263.2.
  • As far as peak fluctuations go, Rapid Micro Biosystems' Net Cash Flow soared by 143030.27% in 2021, and later crashed by 111242.48% in 2024.
  • Over the past 5 years, Rapid Micro Biosystems' Net Cash Flow (Quarter) stood at -$41.2 million in 2021, then soared by 102.99% to $1.2 million in 2022, then crashed by 59.5% to $499000.0 in 2023, then crashed by 1112.42% to -$5.1 million in 2024, then skyrocketed by 112.13% to $613000.0 in 2025.
  • Its Net Cash Flow stands at $613000.0 for Q3 2025, versus -$654000.0 for Q2 2025 and $2.0 million for Q1 2025.